Displacement of Pathogens by an Engineered Bacterium Is a Multifactorial Process That Depends on Attachment Competition and Interspecific Antagonism by Al-Saedi, Fitua et al.
This is a peer-reviewed, final published version of the following document and is licensed under Creative 
Commons: Attribution 4.0 license:
Al-Saedi, Fitua, Stones, Daniel H ORCID: 0000-0002-8981-7943, Vaz, Diana 
Pereira, Krachler, Anne Marie and Payne, S. M. (2016) Displacement of 
Pathogens by an Engineered Bacterium Is a Multifactorial Process That 
Depends on Attachment Competition and Interspecific Antagonism. 
Infection and Immunity, 84 (6). pp. 1704-1711. ISSN 0019-9567 
Official URL: https://doi.org/10.1128/IAI.00020-16
DOI: http://dx.doi.org/10.1128/IAI.00020-16
EPrint URI: http://eprints.glos.ac.uk/id/eprint/6065
Disclaimer 
The University of Gloucestershire has obtained warranties from all depositors as to their title in the material 
deposited and as to their right to deposit such material.  
The University of Gloucestershire makes no representation or warranties of commercial utility, title, or fitness 
for a particular purpose or any other warranty, express or implied in respect of any material deposited.  
The University of Gloucestershire makes no representation that the use of the materials will not infringe any 
patent, copyright, trademark or other property or proprietary rights.  
The University of Gloucestershire accepts no liability for any infringement of intellectual property rights in any 
material deposited but will remove such material from public view pending investigation in the event of an 
allegation of any such infringement. 
PLEASE SCROLL DOWN FOR TEXT.
Displacement of Pathogens by an Engineered Bacterium Is a
Multifactorial Process That Depends on Attachment Competition and
Interspecific Antagonism
Fitua Al-Saedi, Daniel Henry Stones, Diana Pereira Vaz, Anne Marie Krachler
Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
Pathogen attachment to host cells is a key process during infection, and inhibition of pathogen adhesion is a promising approach
to the prevention of infectious disease. We have previously shown that multivalent adhesion molecules (MAMs) are abundant in
both pathogenic and commensal bacterial species, mediate early attachment to host cells, and can contribute to virulence. Here,
we investigated the efficacy of an engineered bacterium expressing a commensal MAM on its surface in preventing pathogen at-
tachment and pathogen-mediated cytotoxicity in a tissue culture infection model. We were able to dissect the individual contri-
butions of adhesion and interspecific antagonism on the overall outcome of infection for a range of different pathogens by com-
parison with the results obtained with a fully synthetic adhesion inhibitor. We found that the potential of the engineered
bacterium to outcompete the pathogen is not always solely dependent on its ability to hinder host attachment but, depending on
the pathogenic species, may also include elements of interspecific antagonism, such as competition for nutrients and its ability to
cause a loss of fitness due to production of antimicrobial factors.
The spread of antibiotic-resistant bacteria is a rising problemand one likely to persist due to the intrinsic mechanism of
action of antibiotics generating selective pressure on bacterial
populations. As a potential way of addressing this challenge,much
work has focused on alternativeways to prevent and treat bacterial
infections, including antivirulence approaches (1). These encom-
pass strategies which target the bacterium’s ability to colonize and
cause disease in a host without interfering with growth or viability
(2). Since initial attachment to eukaryotic cells and tissues is an
essential early step during colonization of a host, a focus of
antivirulence strategies has been the development of adhesion
inhibitors (3). A wide range of living (probiotic or engineered),
semisynthetic, or fully synthetic adhesion inhibitors has been
developed, and ongoing work now focuses on understanding
and improving their efficacy (4–6).
Prior work by our group has investigated the use of live and
semisynthetic inhibitors based onmultivalent adhesionmolecules
(MAMs), which are an abundant family of bacterial adhesins con-
tributing to initial attachment and virulence in a range of patho-
gens (7). A related family of mammalian cell entry (MCE) do-
main-containing proteins is involved in invasion of host cells by
mycobacteria and Leptospira spp. (8–10), and peptides targeting
this interaction inhibit the uptake of Mycobacterium tuberculosis
by host cells (11). Early work focused on materials based on
MAM7 from the seafood-borne pathogen Vibrio parahaemolyti-
cus, which demonstrated good efficacy against a broad range of
Gram-positive and Gram-negative bacterial infections both
in vitro and in vivo (7, 12–15). Nonadherent Escherichia coli BL21
cells expressing V. parahaemolyticus MAM7 on their surface
showed specific adhesion to a range of eukaryotic cells and could
prevent infection with V. parahaemolyticus, Vibrio cholerae, Yer-
sinia pseudotuberculosis, or enteropathogenic E. coli (EPEC) (7).
Subsequent work showed that this effect could be recapitulated by
using a semisynthetic material consisting of recombinant MAM7
chemically coupled to polystyrene beads and that the material
efficiently displaced a wider range of clinically relevant pathogens,
including Gram-positive bacteria (12, 14). However, V. parahae-
molyticus MAM7 was recently shown to interfere with cellular
signaling in intestinal epithelial cells and to increase the permea-
bility of intestinal cell junctions in vitro, on the basis of its ability to
bind to and cluster the signaling lipid phosphatidic acid in host
cells (16, 17). Thus, we set out to characterize a putative MAM
protein from a well-characterized intestinal commensal, Esche-
richia coli strain HS, regarding its ability to mediate attachment
and displace pathogens from host cells during infection. The E.
coli MAM is a protein consisting of 879 amino acids and, like V.
parahaemolyticus MAM7, comprises seven MCE domains. How-
ever, the overall sequence conservation between the two proteins
is low (35%), and ongoing experiments investigating the bio-
chemistry of E. coli MAM-receptor interactions suggest that, un-
like V. parahaemolyticus MAM7, E. coli MAM does not utilize
phosphatidic acids as a host surface receptor (unpublished re-
sults) and therefore may not have the same adverse effects on host
cellular signaling.
By using both a live, engineered bacterium and a semisynthetic
adhesion inhibitor based on the recombinant MAM protein, we
were able to dissect the inhibitory effects of the MAM protein on
pathogens and attribute them to either competitive adhesion by
MAM-based materials or synergistic effects derived from the en-
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gineered bacterial strain. This work demonstrates that competi-
tive displacement of pathogens from the host cell surface can be
achieved by using multivalent adhesion molecules with different
receptor binding specificities and that, depending on the targeted
pathogen, synergistic effects may be derived through the use of a
live adhesion inhibitor, rather than semisynthetic material. This
finding has wider implications not just for the design of future
adhesion inhibitors but also for our understanding of polymicro-
bial interactions with eukaryotic hosts.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used were
Escherichia coli BL21 that expressed MAM from Escherichia coli HS
(MAMHS) from a plasmid (pBAD-MAMHS) or that was transformedwith
the empty pBADplasmid (BL21 control), Pseudomonas aeruginosa PAO1,
Enterococcus faecalis ATCC 49452, and Staphylococcus aureus Newman.
All strains were grown in Luria Bertani (LB) medium at 37°C prior to
infection experiments. The growth medium for BL21 carrying the pBAD
plasmids contained 50g/ml kanamycin and 0.05%arabinose. For strains
transformed with pDP151 expressing mCherry, the medium also con-
tained 100 g/ml ampicillin. The selective plating media used for de-
termination of the numbers of CFU of specific strains following mixed
infections were pseudomonas cetrimide agar for P. aeruginosa, Entero-
coccosel agar for E. faecalis, and mannitol salt agar for S. aureus.
Maintenance of tissue culture cells. HeLa cells were routinely main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (HIFBS), 5 mM L-glu-
tamine, 50g/ml penicillin, and streptomycin in an atmosphere contain-
ing 5% CO2 at 37°C.
Construction of MAMHS expression vectors. For recombinant ex-
pression and purification of the MAM protein from E. coli strain HS
(MAMHS; GenBank accession number ABV06236.1; GI 157066981) in E.
coli BL21, the sequence encoding the soluble portion of the protein (res-
idues 45 to 879) was amplified from E. coliHS genomic DNA. The follow-
ing primers, containing 5=BamHI and 3=XhoI restriction sites, were used:
5=-CAGTGGATCCGACAGTTATCAGGACCGG-3= and 5=-CAGTCTC
GAGTTATTTGGGAAGCGCAGTACC-3=. The insert was cloned into
the pGEX-4T-3 plasmid. For expression of the full-length MAMHS pro-
tein and surface localization, the complete gene was amplified from E. coli
HS genomic DNA using the following primers, containing 5=NcoI and 3=
HindIII restriction sites: 5=-CAGTCCATGGGACACATGAGTCAGGAA
ACG-3= and 5=-CAGTAAGCTTTTATTTGGGAAGCGCAGTACC-3=.
The insert was cloned into pBAD/Myc-His, with the Ampr cassette being
replaced by a Kanr cassette.
Expression and purification of GST-MAMHS protein. Tenmilliliters
of LB medium supplemented with 100 g/ml ampicillin was inoculated
with a colony of E. coli BL21 transformed with pGEX-4T-3 containing the
MAMHS construct and incubatedwith shaking at 37°C overnight. Follow-
ing overnight incubation, 5 ml of the LB broth culture was added per 500
ml of autoinductionmedium supplementedwith 100g/ml of ampicillin,
grown at 225 rpm and 37°C until the culture reached an optical density at
600 nm (OD600) of 0.6 to 0.7, and then incubated at 20°C overnight.
Following incubation, the cultures were centrifuged at 6,000 rpm for 10
min. The bacterial pellets were resuspended in 25 ml of glutathione S-
transferase (GST) lysis buffer (25 mM Tris, pH 7.5, 150 mMNaCl, 1 mM
EDTA, protease inhibitors, lysozyme, DNase I), 20 mM sodium cholate
was added, and then the suspension was incubated at 4°C overnight. The
suspensionwas sonicated on ice twice for 60 s each time (5 s on and 5 s off;
60% output) and centrifuged at 10,000 rpm for 30min at 4°C. The pellets
were discarded, and the supernatants were filtered through a 0.45-m-
pore-size filter. Two milliliters of washed glutathione beads was added to
the supernatant, and the mixture was rotated at 4°C for 2 h. After the
incubation, 20 ml of binding buffer (25 mM Tris, pH 7.5, 150 mMNaCl,
1 mM EDTA) was added to the column containing the beads, and this
wash step was repeated twice. Elution buffer (1.5 ml; 10 mM reduced
glutathione, 50 mM Tris-HCl, pH 8.0) was added to the beads, the mix-
ture was incubated for 15 min, and then the elution buffer was drained;
this step was repeated twice. Finally, 1.5 ml of elution buffer containing
100 mM reduced glutathione was added to the beads, the mixture was
incubated for 15 min, and then the elution buffer was drained. Glutathi-
one was removed from the GST-fusion proteins by dialysis at 4°C over-
night. Protein purity was 90%, as determined by SDS-PAGE.
Coupling of recombinant GST-MAMHS protein to polymer beads.
Fluorescent blue beads of 2 m in diameter (Sigma) were coupled to the
GST-MAMHS protein or theGST protein (control). The detailed protocol
for the coupling procedure has been described elsewhere (18). Briefly, the
washed beads were resuspended in phosphate-buffered saline (PBS) and
incubated with 10 mM sulfo-succinimidyl 4-(p-maleimidophenyl)bu-
tyrate for 1 h at 25°C while they were rotated. After the activated beads
were washed, they were resuspended in PBS containing a final concentra-
tion of 6Mprotein and incubated for 2 h at 25°C. Cysteine (50mM)was
added to quench the reaction, and the beads were washed twice with PBS
and resuspended in fresh PBS to give the final product. The final protein
concentration of the protein-coupled beads used in the experiments was
500 nM, and 2  1011 beads/ml were used.
Attachment assays. To test the ability of E. coli BL21 to adhere to host
cells, HeLa cells were seeded at a concentration of 150,000 cells/ml a day
prior to the experiment, and E. coli BL21 cells transformed with pBAD/
Myc-His-MAMHS (BL21MAMHS) or empty pBAD (control) were
grown in LB broth containing kanamycin on the day before the experi-
ment. For the attachment experiment, E. coli BL21 was grown in LB broth
containing kanamycin, and when the OD600 reached 0.6, protein expres-
sionwas induced by adding arabinose to 0.05%and incubating at 37°C for
a further 4 h. HeLa cells were infected with E. coli BL21 as a control or E.
coli BL21MAMHS at a multiplicity of infection (MOI) of 100 for 1 h.
Following the infection, the DMEMwas removed and the HeLa cells were
washed three timeswith PBS to remove unattached bacteria. TritonX-100
(0.5%) in PBS was added to lyse the HeLa cells, and then serial dilutions
were prepared, cultured on LB agar, and incubated at 37°C for 20 h,
followed by counting of the number of colonies.
Competition experiments. On the day before the experiment, HeLa
cells were seeded at a concentration of 150,000 cells/ml into 24-well plates.
Wells for untreated HeLa cells (negative control) and for Triton X-100
lysis (positive control) were also prepared. The bacteria were grown in LB
broth overnight. When the E. coli BL21 strains were used to compete with
pathogenic bacteria, on the day of the experiment, the strains were grown
and protein expression was induced as described above. Tissue culture
cells were washed with PBS prior to the addition of E. coli BL21 at anMOI
of 100 and either S. aureus,E. faecalis, orP. aeruginosa at anMOIof 10, and
the cells were incubated at 37°C for 4 h. When beads were used in com-
petition experiments, HeLa cells were infected by adding the pathogens at
an MOI of 10 together with 2  1011 beads/ml (GST or GST-MAMHS)
containing protein at a final concentration of 500 nM. Following incuba-
tion for 4 h, supernatant samples were removed for cytotoxicity measure-
ments, and cells were treated as described below for either counting of
attached bacteria or microscopy.
Cytotoxicity measurements. The lactate dehydrogenase (LDH) re-
leased into the medium was quantified using an LDH cytotoxicity detec-
tion kit (TaKaRa), as described in the kit protocol. The data were ex-
pressed as the percent cytotoxicity normalized to that for untreated cells
(0% lysis) and Triton X-100-lysed cells (100% lysis) andwas calculated by
the following formula: percent cytotoxicity  100  [(OD490 for experi-
mental release  OD490 for spontaneous release)/(OD490 for maximum
release  OD490 for spontaneous release)].
Quantification of attached bacteria.Mediumwas removed andHeLa
cells were washed three times with PBS. One milliliter of 0.5% Triton
X-100 in PBSwas added to each well to lyse theHeLa cells. Serial dilutions
of lysed samples were cultured on selective medium as described above,
and the colonies were counted after incubation at 37°C for 20 h.
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Fluorescence microscopy. Following removal of the supernatants,
HeLa cells were washed three times with sterile PBS and fixed using 3.2%
formaldehyde in PBS for 15 min at room temperature. After fixation, the
cells were washedwith PBS and treatedwith 0.1%TritonX-100 in PBS for
5 min to permeabilize the cells. The cells were then stained with either
rhodamine-phalloidin or Alexa Fluor 488-phalloidin and Hoechst for 10
min in the dark. Samples were mounted using ProLong Gold antifade
mounting medium and imaged using a Nikon Ti Eclipse microscope.
Images were processed using ImageJ and Corel Draw X5 software.
RESULTS
Characterization of an engineered bacterium and a synthetic
adhesion inhibitor based on an MAM from commensal E. coli
isolate HS. As an extension of previous work on multivalent ad-
hesion molecules (MAMs) derived from pathogenic Gram-nega-
tive bacterial species (7, 14), we set out to characterize a MAM
derived from a commensal E. coli isolate and to characterize its
potential for and mode of pathogen displacement from host cells
in more detail. For this purpose, we constructed two types of ma-
terials. First, we constructed a conditionally adhesive strain of E.
coli, further referred to as BL21MAMHS. This strainwasmade by
transforming E. coli BL21 with a plasmid expressing the MAM
from commensal E. coli isolate HS from an arabinose-inducible
promoter, thus enabling its surface display in BL21 cells. E. coli
BL21 transformed with pBAD alone served as a negative control.
BL21MAMHS was designed to investigate pathogen displace-
ment from host cells and to capture interactions based on attach-
ment, as well as any additional effects based on intraspecific inter-
actions between BL21 and pathogenic bacteria. Second, we
constructed a synthetic material, consisting of polymer beads
chemically coupled to recombinant GST-tagged MAM derived
from E. coli HS (MAMHS beads). This was made to capture inter-
actions betweenMAM and pathogens solely based on attachment
competition and to distinguish these from secondary effects due
to intraspecific bacterial interactions. In this case, beads coupled
to the GST tag alone (control beads) served as a negative control.
Initially, we characterized the adhesive properties of
BL21MAMHS and BL21 control cells toward host cells using
fluorescence imaging (Fig. 1A to C) as well as enumeration of
attached bacteria by dilution plating (Fig. 1D). To visualize the
attached bacteria, both BL21 control and BL21MAMHS cells
were cotransformed with a plasmid expressingmCherry. The sur-
face expression ofMAMHS conferred adhesive properties to BL21,
with an average of 1,070  250 bacteria being attached per 100
host cells, while BL21 bacteria lacking MAMHS showed little at-
tachment (average, 170 20 bacteria per 100 host cells). Enumer-
ation of attached bacteria by dilution plating revealed a similar
picture: 19% of the BL21 control bacteria and 73% of the
BL21MAMHS bacteria attached relative to the input amount of
bacteria. Neither the BL21 control nor the BL21MAMHS strain
displayed any cytotoxicity toward host cells (Fig. 1E). MAMHS
beadswere also adhesive toward host cells (average, 767 beads/100
cells bound), whereas control beads were not (average, 20 beads/
100 cells attached) (Fig. 2).
Since both BL21MAMHS and MAMHS beads were able to
adhere to host cells, we next tested their ability to displace three
different Gram-positive and Gram-negative bacterial pathogens
from the host cell surface. Pseudomonas aeruginosa, Enterococcus
faecalis, and Staphylococcus aureus are all causative agents of
wound infections and surgical site infections (19–21), and infec-
tions caused by these bacteria are increasingly difficult to treat due
to intrinsic and acquired antimicrobial resistance (22, 23). Since
we are interested in exploiting MAM mimetics to inhibit infec-
tions, we characterized the interactions of BL21MAMHS and
MAMHS beads with these species and with epithelial cells in detail,
FIG 1 MAMHSmediates adhesion of nonadherent E. coli cells to host cells and is nontoxic. (A and B) Attachment of E. coli BL21 cells expressing mCherry (red)
and transformedwith pBAD (A) or pBAD containingMAM from E. coliHS (BL21MAMHS) (B) toHeLa cells. Cells were fixed and stained for actin (green) and
DNA (blue) following a 1-h infection. The arrow indicates attached bacteria. Bar, 20m. (C) The numbers of attached bacteria were quantified by image analysis,
and the data represent the means  SEMs based on analysis of at least 300 HeLa cells over three independent experiments. Significance was determined using
Student’s t test. *, P  0.05. (D) The attachment of BL21 cells to HeLa cells was also quantified by dilution plating, and the results are expressed in relation to the
CFU counts from the input controls (100%). (E) The cytotoxicity of BL21 toward HeLa cells was determined using LDH release assays and is normalized to that
toward untreated (0%) and Triton X-100-treated (100%) controls. The results in panels D and E are means  SEMs (n  3), and significance was determined
using Student’s two-tailed t test. *, P  0.05.
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to test the efficacy and mode of action of both types of inhibitors
and evaluate which approach may be more beneficial.
The inhibitory effect of BL21MAMHS on Pseudomonas
aeruginosa is solely based on competitive replacement from sur-
face receptors.HeLa epithelial cells were incubatedwithP. aerugi-
nosa at a multiplicity of infection (MOI) of 10 or with both P.
aeruginosa (MOI, 10) and the BL21 control or BL21MAMHS
(MOI, 100). Following a 4-h infection, the attachment of P.
aeruginosa and the resulting cytotoxicity on host cells were quan-
tified. The presence of BL21MAMHS led to a significant decrease
in both the number of attached P. aeruginosa cells (3-fold reduc-
tion) and the resulting cytotoxicity (18-fold reduction) for host
cells, while no significant changes were observed with P. aerugi-
nosa in the presence of the BL21 control (Fig. 3). We further stud-
ied the intraspecific interactions between E. coli BL21 and P.
aeruginosa. Coincubation of both species in liquid broth had no
effect on the numbers of either P. aeruginosa (Fig. 3C) or BL21
(Fig. 4) cells. Infection of epithelial cells with P. aeruginosa in the
presence of MAMHS beads but not control beads equally led to a
significant decrease in both the level of P. aeruginosa attachment
to host cells (2-fold reduction) and cytotoxic effects on host cells
(4-fold reduction) (Fig. 3G and H). These results were also con-
firmed by visual inspection of infected cells (Fig. 3D to F, I, and J).
The inhibitory effect of BL21MAMHS on Enterococcus
faecalis is due to a combination of attachment competition and
competition for nutrients. A previous study by our group (14)
showed that, due to overlap in the host receptors utilized by
MAMs and many Gram-positive bacterial fibronectin-binding
adhesins, MAMs also have the ability to displace Gram-positive
bacterial pathogens from the host cell surface. We therefore
FIG 2 Polymer beads coupled to MAMHS adhere to host cells. (A and B) Attachment of polystyrene beads (blue) coupled to GST (A) or GST-MAMHS (B) to
HeLa cells (F-actin stained green). Bar, 10 m. (C) The numbers of attached bacteria were quantified by image analysis, and data represent the means  SEMs
based on analysis of at least 300 HeLa cells over three independent experiments. Significance was determined using Student’s t test. ***, P  0.001.
FIG 3 The inhibitory effect of BL21MAMHS on Pseudomonas aeruginosa (PA) is based on competitive replacement from surface receptors. HeLa cells were
infectedwithP. aeruginosa (MOI, 10) alone or in the presence of either the BL21 control or the BL21MAMHS strain. Alternatively, HeLa cells were infectedwith
P. aeruginosa (MOI, 10) alone or in the presence of either GST-coupled control beads orMAMHS-coupled beads. After 4 h, the numbers of attached P. aeruginosa
cells were determined by selective plating (A, G) and cytotoxicity toward HeLa cells was determined by LDH release assays (B, H). Cytotoxicity was normalized
against that for uninfected (0%) and Triton X-100-lysed (100%) samples. The morphology of infected HeLa cells following infections was determined by
imaging. The staining in panels D to F shows DNA (blue) and F-actin (red). Bar, 20 m. The staining in panels I and J shows beads (blue) and F-actin (green).
(C) Mixed planktonic cultures of P. aeruginosa and BL21 were grown for 4 h, and the number of P. aeruginosa cells was determined by selective plating. Results
are means  SEMs (n  3), and significance was determined using Student’s two-tailed t test on raw data. *, P  0.05; **, P  0.01; ns, no significant difference.
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tested the effect of BL21MAMHS on infection with E. faecalis.
Both BL21MAMHS and the BL21 control strain lackingMAMHS
significantly decreased the number of host cell-bound E. faecalis
cells (2-fold reduction; Fig. 5A). They both also decreasedE. faeca-
lis-mediated cytotoxicity toward host cells, but the effect of
BL21MAMHS was greater (20-fold reduction) than that ob-
served with the BL21 control strain (3-fold reduction) (Fig. 5B).
Visualization of the infection further confirmed these results
(Fig. 5D to F). Quantification of both E. coli and E. faecalis follow-
ing a 4-h coincubation in liquid broth showed that both E. coli and
E. faecalis were significantly inhibited by each other’s presence
(Fig. 4 and 5C). To distinguish these intraspecific bacterial inter-
actions from inhibitory effects due to attachment competition, we
investigated the effect of MAMHS beads on E. faecalis infection.
While MAMHS beads decreased the attachment of E. faecalis cells
to host cells (2-fold reduction) as well as cytotoxicity (2-fold re-
duction), control beads had no effect on either readout (Fig. 5G
and H). Visualization of bead-based inhibition confirmed these
results; attachment of MAMHS beads to host cells had a protective
effect, and more epithelial cells than cells infected in the presence
of control beads maintained an intact morphology (Fig. 5I and J).
The inhibitory effect of BL21MAMHS on Staphylococcus
aureus is due to a combination of attachment competition and
interspecific antagonism. S. aureus is a Gram-positive opportu-
nistic pathogen which has previously been shown to be inhibited
by the binding of bead-coupledV. parahaemolyticusMAM to host
cells. A similar decrease of S. aureus adhesion to host cells (8-fold
reduction) and cytotoxicity toward host cells (7-fold reduction)
was observed here when we used bead-coupled MAMHS as the
competingmoiety. In contrast, incubation in the presence of con-
trol beads had no significant effect on either S. aureus attachment
or cytotoxicity toward host cells (less than 2-fold reduction; Fig.
6G to J). Interestingly, whenwe used BL21MAMHS as the inhib-
itor against S. aureus, a significant effect on attachment and cyto-
toxicity was observed even with the control strain (Fig. 6A to F).
Coincubation with BL21 lacking MAMHS led to a slight decrease
FIG 4 Interactions between pathogens and E. coli BL21 during growth. E. coli
BL21was grown alone or asmixed cultures of E. coliBL21 and either E. faecalis,
P. aeruginosa, or S. aureus for 4 h. The numbers of E. coli BL21 cells were
determined by selective plating. Results are means  SEMs (n  3), and sig-
nificance was determined using Student’s two-tailed t test on raw data. *, P 
0.05 compared to the growth of BL21 alone; **, P  0.01 compared to the
growth of BL21 alone; ns, no significant difference compared to the growth of
BL21 alone.
FIG 5 The inhibitory effect of BL21MAMHS on Enterococcus faecalis (EF) is due to a combination of attachment competition and competition for nutrients.
HeLa cells were infected with E. faecalis (MOI, 10) alone or in the presence of either the BL21 control or the BL21MAMHS strain. Alternatively, HeLa cells were
infected with E. faecalis (MOI, 10) alone or in the presence of either GST control beads or MAMHS-coupled beads. After 4 h, the numbers of attached E. faecalis
cells were determined by selective plating (A, G) and cytotoxicity toward HeLa cells was determined by LDH release assays (B, H). Cytotoxicity was normalized
against that for uninfected (0%) and Triton X-100-lysed (100%) samples. The morphology of infected HeLa cells following infections was determined by
imaging. The staining in panels D to F showsDNA (blue) and F-actin (red). Bar, 20m. The staining in panels I and J shows the beads (blue) and F-actin (green).
(C) Mixed planktonic cultures of E. faecalis and BL21 were grown for 4 h, and the number of E. faecalis cells was determined by selective plating. Results are
means  SEMs (n  3), and significance was determined using Student’s two-tailed t test on raw data. *, P  0.05; **, P  0.01; ***, P  0.001; ns, no significant
difference.
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in both attachment and cytotoxicity (2-fold). However, the in-
hibitory effect wasmore pronouncedwith BL21MAMHS (6-fold
reduction of both adherence and cytotoxicity), and the effects
achieved with the BL21 control and BL21MAMHS strains were
significantly different both visually and on the basis of the results
of quantitative assays (Fig. 6A, B, and D to F).When S. aureus and
E. coli BL21 were grown together in the absence of host cells, S.
aureus growth was unaffected (Fig. 6C), but the growth of BL21
was significantly diminished (Fig. 4). We performed follow-up
experiments to identify the nature of the inhibition that S. aureus
exerts on E. coli. Filtered supernatant isolated from S. aureus cul-
tures was spotted on filter disks and caused a visible zone of inhi-
bition on a lawn of E. coli after 16 h of incubation at 37°C (data not
shown). Thus, S. aureus likely produces a secreted factor which
inhibits the growth of E. coli BL21.
DISCUSSION
The ability of bacteria to intimately adhere to host cells and tissues
is a conserved feature in bacteria capable of a host-associated life
style and essential for successful interactions between bacteria and
the host. Thismakes adherence a potential target for antivirulence
approaches, and we have previously shown that materials based
on theV. parahaemolyticus proteinMAM7 can efficiently displace
a broad range of Gram-positive and Gram-negative bacterial
pathogens of clinical importance. Due to the potential interfer-
ence of the initially used adhesin, MAM7 from V. parahaemolyti-
cus, with host cell function and its ability to enhance transcellular
permeability in cultured intestinal epithelial cells, we shifted our
focus to anMAMprotein from the well-characterized commensal
HS strain of E. coli.
Commensal strains of E. coli can strongly adhere to epithelial
cells without any ill effects, and this property has been shown to be
mediated by a range of adhesins, including fimbriae and flagella
(24, 25). These adhesive properties have previously been shown to
be essential for commensal strains’ ability to displace enteric
pathogens, such as Salmonella enterica serovar Typhimurium and
pathogenic E. coli (25–27). By heterologous surface expression of
MAM from E. coli HS in the surrogate, nonadherent strain E. coli
BL21, we created an engineered, adhesive strain for which adher-
ence is solely based on MAM. We also created a semisynthetic
material consisting of polystyrene beads with dimensions similar
to those of E. coli chemically and directionally coupled to MAM
from E. coli HS (MAMHS). This further allowed us to dissect any
observed interactions between the materials and pathogens and
attribute them to either adhesion or additional intraspecies inter-
actions between E. coli and the pathogens used.
The results obtained with both BL21MAMHS and the
bead-based inhibitor showed that MAMHS mediates specific
and strong adherence to host cells. The binding affinity and
avidity of MAMHS seem to be comparable to those of V. para-
haemolyticus MAM7 and the MAM protein from enteropatho-
genic E. coli (EPEC), as it mediates the adherence of otherwise
nonadherent BL21 to host cells to a similar extent as MAM7
and EPEC MAM (7).
The ability to displace pathogens from the host surface appears
to be a conserved feature among MAMs, as BL21MAMHS was
FIG 6 The inhibitory effect of BL21MAMHS on Staphylococcus aureus (SA) is due to a combination of attachment competition and interspecies antagonism.
HeLa cells were infected with S. aureus (MOI, 10) alone or in the presence of either the BL21 control or the BL21MAMHS strain. Alternatively, HeLa cells were
infected with S. aureus (MOI, 10) alone or in the presence of either GST-coupled control beads or MAMHS-coupled beads. After 4 h, the numbers of attached S.
aureus cells were determined by selective plating (A, G) and cytotoxicity toward HeLa cells was determined by LDH release assays (B, H). Cytotoxicity was
normalized against that for uninfected (0%) and Triton X-100-lysed (100%) samples. The morphology of infected HeLa cells following infections was deter-
mined by imaging. The staining in panelsD to F showsDNA(blue) and F-actin (red). Bar, 20m.The staining in panels I and J shows the beads (blue) and F-actin
(green). (C) Mixed planktonic cultures of S. aureus and BL21 were grown for 4 h, and the number of S. aureus cells was determined by selective plating. Results
are means  SEMs (n  3), and significance was determined using Student’s two-tailed t test on raw data. *, P  0.05; **, P  0.01; ns, no significant difference.
Displacement of Pathogens by an Engineered Bacterium
June 2016 Volume 84 Number 6 iai.asm.org 1709Infection and Immunity
 o
n
 O
ctober 9, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
able to decrease both the attachment and cytotoxicity of all three
pathogens tested here. As is the case with Vibrio MAM7-based
inhibitors (13, 14), MAMHS was able to displace both Gram-pos-
itive andGram-negative bacterial pathogens. The biochemical ba-
sis of this behavior will require further investigation, as our initial
characterization of MAMHS host receptor binding has demon-
strated that it does not have the same ligand binding specificity as
Vibrio MAM7, which utilizes phosphatidic acids as a main recep-
tor (28). While the lack of MAMHS affinity toward phosphatidic
acidsmeans that the protein likely does not interfere with host cell
signaling in the same way that V. parahaemolyticus MAM7 does,
further work is needed to identify its host surface receptor.
Previous work comparing the inhibitory properties of live bac-
teria expressing MAM7 and bead-coupled MAM7 have largely
yielded similar results with bothmaterials. Bothmaterials showed
broad efficacy against V. parahaemolyticus, V. cholerae, Yersinia
pseudotuberculosis, enteropathogenic E. coli, Pseudomonas aerugi-
nosa, Klebsiella pneumoniae, and Acinetobacter spp. but had com-
parable activities against these bacteria, and no synergies were
observedwith the use of live bacteria over bead-basedmaterials (7,
13). These results were recapitulated here with P. aeruginosa, in
that both bead-based and livematerials had comparable effects on
this species, and no effects were observed with the BL21 control
strain (12). In the present study, synergies due to intraspecific
interactions were restricted to those against the Gram-positive
bacterial isolates, and none of these were previously investigated
with live adhesion inhibitors. However, the effects observed here
with the bead-based adhesion inhibitor on S. aureus strain New-
man were similar to the effects that we previously observed with
MAM7 beads and S. aureus USA300 (14).
A comparison of the effects of the bacterium- and bead-based
inhibitors on infection of host cells with E. faecalis showed a clear
synergistic effect of the engineered bacteria.While the bead-based
inhibitor halved the level of E. faecalis-mediated cytotoxicity,
BL21MAMHSdecreased the toxicity approximately 10-fold (Fig.
5). Further investigation showed that E. faecalis and E. coli limit
each other’s growth, most likely through competition for shared
nutrients (Fig. 4 and 5C).While this implies a similar limitation of
the growth of E. coli during the competition experiment, this
growth limitation does not seem to affect its potential to outcom-
pete E. faecalis, most likely due to the initial excess of E. coli over E.
faecalis in the experiment.
In the case of S. aureus, the bacterium- and bead-based inhib-
itors had comparable overall effects on the outcome of infection (a
5-fold versus 4- to 5-fold reduction in S. aureus-mediated cyto-
toxicity, respectively). However, coincubation with the BL21 con-
trol also led to a partial decrease in both adherence and cytotox-
icity. The interaction between S. aureus and E. coli seems to be
characterized by a one-sided inhibition of E. coli growth by S.
aureus, whereas E. coli has no inhibitory effect on S. aureus growth
(Fig. 4 and 6C). The basis of this one-sided inhibition could be
production of a bacteriocin or other secreted inhibitory factors,
such as bacteriolytic enzymes, by S. aureus, since the sterile super-
natant of an S. aureus culture is sufficient to cause a zone of clear-
ance on a lawn of E. coli BL21 cells. S. aureus is known to produce
a wide range of antimicrobial factors, including several which
show activity against Gram-negative bacteria (29, 30). While this
production of antimicrobials by S. aureusmay lead to a decrease in
its capacity to adhere and cause cytotoxicity, this effect does not
ultimately lead to synergy with MAM-mediated competitive dis-
placement, since the number of S. aureus cells does not decrease
through the presence of BL21. The use of a bacteriocin-resistant
strain ofE. coli as a surrogatemay be away tomaintain the number
of E. coli cells during the competition and may thus encourage
synergistic effects.
In summary, this study demonstrates that competitive replace-
ment of pathogens is a shared feature ofMAMs and that the use of
engineered live, adhesive bacterial strains may have beneficial ef-
fects on the outcome of the competition, beyond the competitive
binding of MAM to host cells. These synergies depend on the
nature of the competing pathogen and may involve competition
for nutrients or trade-offs between the production of antimicro-
bials and the production of colonization and virulence factors.
These added layers of complexity are an important consideration
not only in the future design of adhesion inhibitors but also in
thinking about polymicrobial interactions in the context of a host
in general.
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